Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Lemonade

Insurance Stocks Moving In Tuesday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Insurtech Bet Lemonade Stock Is Low Enough to Buy Now

Insurtech Bet Lemonade Stock Is Low Enough to Buy Now

Lemonade (LMND) has been a post-IPO disappointment, but a unique joining of AI and insurance could produce a long-term winner.

Insurance Stocks Moving In Wednesday's Intraday Session

Insurance Stocks Moving In Wednesday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Lemonade Foundation Announces Formation Of Crypto Climate Coalition: What You Need To Know

Lemonade Inc’s (NYSE: LMND) The Lemonade Foundation announced Tuesday the formation of the Lemonade Crypto Climate Coalition.

What 5 Analyst Ratings Have To Say About Lemonade

Within the last quarter, Lemonade (NYSE:LMND) has observed the following analyst ratings:

Lemonade vs. Root: Which Insurance Stock is a Better Choice?

Today I'll analyze Lemonade (LMND) and Root (ROOT) to determine which insurance stock is a better buy.

Why Lemonade Stock Is Trading Lower During Wednesday's After-Hours Session

Shares of Lemonade Inc. (NYSE: LMND) tanked during Wednesday’s after hours session following the release of the company’s Q4 earnings results and weak Q1 guidance.

inkl

Read news from The Economist, FT, and more,
with one subscription

Lemonade: Q4 Earnings Insights

Lemonade: Q4 Earnings Insights

Lemonade (NYSE:LMND) reported its Q4 earnings results on Wednesday, February 23, 2022 at 05:00 PM. Here's what investors need to know about the announcement. Earnings Lemonade missed estimated earnings by 0.88%, reporting an EPS of $-1.14 versus an estimate of $-1.13.

Thinking About Buying Stock In Clover Health, Jumia Or Lemonade?

Thinking About Buying Stock In Clover Health, Jumia Or Lemonade?

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends.

Organisations

Tian Ruixiang Holdings

Reliance Global Group

Kingstone Companies

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play